Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

12.01.15	Seattle Genetics, Bristol-Myers Report Clinical Trial Collaboration (RTTNews)
12.01.15	Bristol-Myers : Opdivo Demonstrates Superior Overall Survival In Phase 3 Trial (RTTNews)
05.01.15	Bristol-Myers, Calibr Announce Worldwide Research Collaboration - Quick Facts (RTTNews)
22.12.14	FDA Approves Bristol-Myers' Opdivo For Advanced Melanoma (RTTNews)
07.12.14	BMY:Opdivo Shows High Overall Response Rate Of 87% For Relapsed Or Refractory HL (RTTNews)
06.12.14	Bristol-Myers:Opdivo Shows Response Rate Of 87% For Treatment Of Relapsed Or RHL (RTTNews)
25.11.14	FPRX Gets High Five, CLRX Put On Notice, RNA Snapped Up, Natesto Changes Hands (RTTNews)
24.11.14	Bristol-Myers, Five Prime Therapeutics Enter Into Clinical Collaboration Deal (RTTNews)
17.11.14	Bristol-Myers Squibb Announces Addl. Data From AVERT Trial - Quick Facts (RTTNews)
17.11.14	Portola,Bristol-Myers, Pfizer Announce Results From First Part Of Phase 3 ANNEXA (RTTNews)
16.11.14	Bristol-Myers Announces Positive Results From CheckMate -066 Study For Melanoma (RTTNews)
14.11.14	Bristol-Myers Squibb To Set Up New Facility In Ireland - Quick Facts (RTTNews)
08.11.14	Bristol-Myers Squibb Reports Data On UNITY Trial (RTTNews)
08.11.14	Bristol-Myers Squibb Announces Data From ALLY Trial For Daclatasvir, Sofosbuvir (RTTNews)
08.11.14	Achillion's Phase 2 Trial Of ACH-3102, Sofosbuvir Meets Primary Objective (RTTNews)
03.11.14	Bristol-Myers Squibb Gets Option To Buy Galecto Biotech - Quick Facts (RTTNews)
30.10.14	Bristol-Myers, Lonza Expand Manufacturing Agreement (RTTNews)
24.10.14	Bristol-Myers Squibb Q3 Profit Rises, Adj. EPS Tops View (RTTNews)
24.10.14	Bristol-Myers Squibb Q3 Profit Tops View - Quick Facts (RTTNews)
24.10.14	Earnings Watch For October 24 (BMY, F, PG, SHPG, UPS) (RTTNews)
13.10.14	Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA (RTTNews)
08.10.14	Bristol-Myers Says Successfully Resolved All U.S. Patent Litigation On Efavirenz (RTTNews)
07.10.14	Bristol-Myers Withdraws New Drug Application For Asunaprevir (RTTNews)
07.10.14	Bristol-Myers Withdraws NDA For Asunaprevir - Quick Facts (RTTNews)
06.10.14	Bristol-Myers Squibb Announces Collaboration To Evaluate Opdivo (RTTNews)
06.10.14	Novartis Signs Clinical Collaboration Deal With Bristol-Myers - Update (RTTNews)
06.10.14	Novartis Enters Clinical Collaboration With Bristol-Myers Squibb - Quick Facts (RTTNews)
01.10.14	Portola Pharma: Phase 3 ANNEXA-A Study Of Andexanet Alfa, Eliquis Met Endpoints (RTTNews)
30.09.14	Bristol-Myers To Transfer $1.4 Bln In U.S. Pension Obligations To Prudential (RTTNews)
29.09.14	Bristol-Myers: EMA Validates Marketing Authorization Application For Nivolumab (RTTNews)
29.09.14	Bristol-Myers Squibb Announces Positive Phase 3 Data For Opdivo - Quick Facts (RTTNews)
02.09.14	Alder Regains Rights To Anti-Inflammation Drug Clazakizumab - Quick Facts (RTTNews)
27.08.14	Bristol-Myers: EU Approves Daklinza For Treating Chronic Hepatitis C Infection (RTTNews)
27.08.14	Bristol-Myers Says Daklinza Gets EU Approval For Chronic Hepatitis C Infection (RTTNews)
21.08.14	FDA Approves Eliquis For Treatment Of Deep Vein Thrombosis, Pulmonary Embolism (RTTNews)
29.07.14	Bristol-Myers, Pfizer Announces EC Approval Of Eliquis For DVT & PE Treatment (RTTNews)
17.07.14	Bristol-Myers, Pfizer Report First Patient Enrollment In Phase IV EMANATE Trial (RTTNews)
10.07.14	Bristol-Myers Squibb To File Biologics Licensing Application For Opdivo In Q3 (RTTNews)
07.07.14	Bristol-Myers Says Daklinza+Sunvepra Dual Regimen For HCV Gets Japan Approval (RTTNews)
07.07.14	Bristol-Myers: Japan Approves Hepatitis C Treatment With Daklinza And Sunvepra (RTTNews)
27.06.14	Eliquis Gets CHMP Positive Opinion For Deep Vein Thrombosis & Pulmonary Embolism (RTTNews)
27.06.14	Bristol-Myers Squibb Gets Positive CHMP Opinion For Daklinza - Quick Facts (RTTNews)
25.06.14	Bristol-Myers Ends Phase 3 Melanoma Study Early Due To Superior Overall Survival (RTTNews)
24.06.14	Bristol-Myers Expands Access To Clinical Trial Data - Quick Facts (RTTNews)
09.06.14	Bristol-Myers Squibb Appoints Giovanni Caforio COO - Quick Facts (RTTNews)
03.06.14	Bristol-Myers, Syngene Extend Research Collaboration In India - Quick Facts (RTTNews)
02.06.14	Bristol-Myers Reports Survival Rates From Phase 1b Trial Of Nivolumab And Yervoy (RTTNews)
02.06.14	Bristol-Myers Squibb Reports Results From Phase 3 Study On Yervoy - Quick Facts (RTTNews)
27.05.14	Bristol-Myers, Incyte Establish Clinical Trial Collaboration On Immunotherapies (RTTNews)
19.05.14	Bristol-Myers, AbbVie Say Elotuzumab Gets FDA Breakthrough Therapy Designation (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester